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INTRODUCTION
The mammalian reoviruses are a tractable experimen-
tal system for studies of viral replication and pathogen-
esis. Reovirus virions are nonenveloped, double-shelled
particles containing a genome of 10 segments of double-
stranded RNA (Nibert and Schiff, 2001). Reoviruses have
been isolated from many mammalian species, including
humans, but reovirus disease is limited to the very young
(Tyler, 2001). The pathogenesis of reovirus infection has
been studied using newborn mice, in which serotype-
specific patterns of disease have been identified (Tyler,
2001). The best characterized of these models is reovirus
pathogenesis in the murine central nervous system
(CNS) (Fig. 1). After primary replication in the intestine,
type 1 reovirus strains spread by hematogenous routes
to the CNS where they infect ependymal cells, leading to
nonlethal hydrocephalus (Weiner et al., 1977, 1980; Tyler
et al., 1986). In contrast, type 3 reoviruses spread primar-
ily by neural routes to the CNS and infect neurons,
causing fatal encephalitis (Weiner et al., 1977, 1980; Tyler
et al., 1986; Morrison et al., 1991). These distinct patterns
of disease segregate genetically with the S1 gene
(Weiner et al., 1977, 1980; Tyler et al., 1986), which en-
codes the viral attachment protein, 1 (Weiner et al.,
1980; Lee et al., 1981). These findings have led to the
hypothesis that selective recognition of cell-surface re-
ceptors by 1 is responsible for the serotype-specific
expression of reovirus-induced disease. For this reason,
considerable effort has been focused on studies of 1
structure, 1 receptors, and mechanisms by which 1–
receptor interactions lead to cellular injury.
1 IS A FIBROUS PROTEIN WITH
HEAD-AND-TAIL MORPHOLOGY
Analysis of structure–function relationships of reo-
virus attachment protein 1 has focused primarily on
type 3 1, with neurovirulent strain type 3 Dearing
(T3D) serving as a prototype. Type 1 1 has been less
well studied, and published reports have been limited
to strain type 1 Lang (T1L). Current understanding of
1 biology is derived from studies of virion-associated
1 as well as 1 protein isolated from virions or
produced using prokaryotic or eukaryotic expression
systems. This body of research has culminated in a
model of 1 structure in which sequences involved in
receptor binding are correlated with distinct morpho-
logic domains of the molecule (Fig. 2).
The 1 protein consists of an elongated fibrous do-
main—the tail—that inserts into the virion and a virion-
distal globular domain—the head (Banerjea et al., 1988;
Furlong et al., 1988; Fraser et al., 1990). Four distinct and
tandemly arranged morphologic regions within the 1
tail domain have been designated T(i) to T(iv) based on
relative proximity to the virion surface (Fraser et al.,
1990). Correlation of 1 primary amino acid sequence
with morphologic data suggests that these morphologic
domains correspond to discrete regions of predicted
secondary structure, primarily -helix and -strand/-
turn (Nibert et al., 1990). The 1 protein forms a trimer
(Leone et al., 1991; Strong et al., 1991), and sequences in
tail region T(ii) predicted to form -helical coiled coil are
required for trimer stability (Wilson et al., 1996; Chappell
et al., 2000).
Type 3 1 contains two receptor-binding domains, one in
the head that binds junction adhesion molecule (JAM) (Bar-
ton et al., 2001b) and another in the tail that binds -linked
sialic acid (Chappell et al., 2000). In T3D 1, these domains
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are dissociable by treatment of 1 with the intestinal pro-
teases trypsin or chymotrypsin (Nibert et al., 1995; Chappell
et al., 1998). The carboxy-terminal tryptic cleavage product,
consisting of a portion of the tail and the entire head
domain, contains the full complement of sequences re-
quired for high-affinity binding to JAM (Barton et al., 2001b).
The amino-terminal 1 cleavage product contains all se-
quences necessary for binding sialic acid (Nibert et al.,
1995; Chappell et al., 1998). Results of experiments using
expressed 1 truncation mutants and chimeric molecules
derived from T1L and T3D 1 proteins demonstrate that the
sialic-acid-binding domain of type 3 1 is contained within
tail region T(iii) (Chappell et al., 2000), an approximately
65-residue segment of sequence (Nibert et al., 1990). Se-
quence diversity within the T(iii) region determines the
capacity of field-isolate reovirus strains to bind sialic acid
(Dermody et al., 1990) and infect murine erythroleukemia
(MEL) cells (Rubin et al., 1992), in which viral infection is
dependent on sialic acid binding (Chappell et al., 1997).
Thus, residues in this vicinity may form part of a sialic-acid-
binding site. Sequences in the head that bind JAM have not
been identified.
The relative importance of individual receptor-binding
domains in type 3 1 for efficient attachment and infec-
tion of host cells is cell type dependent. For example,
sequences in the head domain are essential for attach-
ment to L929 (L) cells and HeLa cells (Nibert et al., 1995;
Chappell et al., 1998; Barton et al., 2001a). However,
sialic-acid-binding sequences in the T(iii) region of the
tail are required for viral attachment to MEL cells (Chap-
pell et al., 1997; Barton et al., 2001a) but are dispensable
for attachment to L cells (Chappell et al., 1997; Barton et
al., 2001a). Head-forming sequences contain determi-
nants of reovirus virulence and tropism in the brain
following intracranial inoculation of newborn mice
(Spriggs and Fields, 1982; Spriggs et al., 1983; Bassel-
Duby et al., 1986). Presumably, these phenotypes are
mediated at the level of 1–receptor interactions, though
this mechanism remains to be proven.
As with its type 3 homologue, type 1 1 binds JAM
FIG. 1. Neuropathogenesis of reovirus infection. Key serotype-depen-
dent differences in reovirus pathogenesis in newborn mice are shown
schematically.
FIG. 2. Reovirus attachment protein 1. (A) Computer-processed electron micrograph of 1 showing morphologic regions: T(i), T(ii), T(iii), T(iv), and
H. Image adapted from Fraser et al. (1990). (B) Predicted secondary structures and functional domains of 1. Morphologic regions T(i) and T(ii) are
predicted to be formed by -helical coiled coil. Regions T(iii), T(iv), and H are predicted to be formed by -strand and -turn. Morphologic region H
corresponds to the globular 1 head. Sequences in type 3 1 required for stability of 1 oligomers, binding sialic acid, and susceptibility to protease
cleavage (arrow) are contained in the 1 tail, whereas sequences required for binding JAM and neutralization of viral infectivity reside in the 1 head.
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(Barton et al., 2001b) and carbohydrate (Lerner et al.,
1963), but the nature of the glycosyl ligand remains
unknown. In contrast to type 3 1, the carbohydrate-
binding domain of type 1 1 has been mapped to tail
region T(iv) (Chappell et al., 2000). The JAM-binding do-
main of type 1 1 also has not been identified. Further
delineation of 1 structure–function relationships awaits
high-resolution structural analysis of 1 complexed with
its receptors.
REOVIRUS BINDS TO CELLS BY MULTISTEP
ADHESION STRENGTHENING
Localization of the sialic-acid-binding domain of type 3
1 to morphologic region T(iii) in the tail provided the first
direct evidence for two distinct receptor-binding domains
in 1. To determine how sialic acid is utilized in reovirus
attachment and tropism, we used reassortant genetics to
isolate monoreassortant viruses containing the S1 gene
of either non-sialic-acid-binding strain T3C44 (Dermody
et al., 1990) (strain T3SA) or sialic-acid-binding strain
T3C44-MA (Chappell et al., 1997) (strain T3SA) and all
other gene segments from T1L (Barton et al., 2001a).
T3SA and T3SA demonstrate cell-specific tropism
attributed to the S1 gene segments of their respective
type 3 parental strains, with T3SA, but not T3SA,
capable of hemagglutination and growth in MEL cells. In
concordance with these results, T3SA binds sialic acid
with nanomolar avidity, while T3SA displays no specific
interaction with sialic acid (Barton et al., 2001a). Despite
this difference in sialic-acid-binding capacity, competi-
tion-binding experiments demonstrate that the 1 head
of both T3SA and T3SA binds JAM (Barton et al.,
2001a). Thus, these reassortant strains display the bio-
logical and biochemical characteristics expected of an
isogenic mutant pair differing solely in the capacity to
bind sialic acid.
Although both T3SA and T3SA replicate with
equivalent efficiency in L cells, T3SA replicates 100-
fold more efficiently in HeLa cells than does T3SA
(Barton et al., 2001a). This difference was exploited to
identify mechanisms by which utilization of sialic acid as
a coreceptor can enhance reovirus infection. The steady-
state avidity of these strains for L cells is nearly equiv-
alent (KD  3  10
11 M) as shown by radioligand
binding assays. In contrast, the avidity of T3SA for
HeLa cells is five-fold higher than that of T3SA (Barton
et al., 2001a). Kinetic assessments of binding indicate
that the capacity to bind sialic acid functions primarily to
increase the k on of virus attachment to HeLa cells. Bind-
ing of T3SA to HeLa cells proceeds through a time-
dependent adhesion-strengthening process (Barton et
al., 2001a). T3SA binding to HeLa cells is characterized
initially by a rapid k on and k off and then transitions to a
higher-avidity binding state with a slower k off. The en-
hanced infectivity of T3SA is mediated by the interac-
tion of 1 with cell-surface sialic acid, since preincuba-
tion of virus with sialyllactose (SLL) dramatically reduces
the efficiency of T3SA infection, yet has no effect on
T3SA infectivity (Barton et al., 2001a). However, sialic-
acid-mediated enhancement of T3SA infection occurs
only during the initial phases of virus–cell interaction,
since SLL does not inhibit productive binding of T3SA
after the first 30 min of virus adsorption. In contrast, Fab
fragments of an antibody directed to the 1 head neu-
tralize T3SA infection efficiently, even when added at
late times during adsorption (Barton et al., 2001a).
Results of binding studies using T3SA and T3SA
indicate that the interaction of reovirus with the cell
surface is complex, with multiple cellular molecules en-
gaging 1 in a thermodynamically and temporally coor-
dinated process that determines the outcome of the
attachment event. For sialic-acid-binding reovirus
strains, the initial interaction between the viral particle
and the host cell is likely mediated by sialic acid due to
the high surface concentration of this carbohydrate. By
virtue of its rapid association rate, virus binding to sialic
acid would adhere the virion to the cell surface, thereby
enabling it to diffuse laterally until it encounters the 1
head receptor. Such lateral diffusion has been reported
for influenza virus (Sagik et al., 1954) and phage T4
(Wilson et al., 1970). For the cell types tested, the inter-
action between JAM and the 1 head is the only binding
option available for type 3 strains that do not bind sialic
acid, thereby slowing the association rate of these
strains for cells that express low levels of JAM. This
attachment strategy is like that of the alphaherpesvi-
ruses, in which virus adheres to the cell surface via
interactions with heparan sulfate until penetration is trig-
gered by the binding of glycoprotein D to one of a family
of herpesvirus entry mediators (Spear et al., 1992; Mont-
gomery et al., 1996; Rajcani and Vojvodova, 1998).
JUNCTION ADHESION MOLECULE
IS A REOVIRUS RECEPTOR
To dissect the influence of viral attachment on reovirus
tropism and disease, we used a FACS-based expres-
sion–cloning approach to identify cellular molecules that
bind the 1 head (Barton et al., 2001b). For these exper-
iments, non-sialic-acid-binding strain T3SA (Barton et
al., 2001a) was used as an affinity ligand to avoid the
potential complication of isolating heavily glycosylated
molecules that do not interact specifically with 1. A
neural precursor cell (NT2) cDNA library was selectively
enriched for cDNAs that confer binding of fluorescein-
ated T3SA virions to transfected COS-7 cells. After four
rounds of FACS enrichment and screening of subpools,
four clones were identified that conferred T3SA binding
to all transfected cells. All four clones encoded human
JAM (hJAM), a member of the immunoglobulin (Ig) super-
family involved in regulation of intercellular tight junction
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(TJ) formation (Martin-Padura et al., 1998; Williams et al.,
1999; Liu et al., 2000).
Anti-hJAM monoclonal antibodies (mAbs) (Liu et al.,
2000) were first used to test the hypothesis that reovirus
binding to JAM is required to initiate an infectious cycle.
Treatment of NT2 cells with anti-hJAM mAbs abolishes
the binding of T3SA and reduces the binding of T3SA
(Barton et al., 2001b). Preincubation of T3SA virions
with SLL results in complete inhibition of binding when
NT2 cells are treated with an hJAM-specific mAb prior to
adsorption with T3SA, confirming that sialic-acid-bind-
ing strains engage both hJAM and sialic acid during
attachment. Treatment of NT2 cells with anti-hJAM mAbs
reduces the binding of both T1L and T3D (Barton et al.,
2001b), suggesting that JAM is a serotype-independent
reovirus receptor. Blockade of T3SA binding to JAM
also inhibits viral infection. Using both immunofluores-
cence and plaque assays to assess viral growth, infec-
tion of NT2 cells, HeLa cells, and Caco-2 cells by T3SA
is almost completely abolished by preincubation with
hJAM-specific mAbs (Barton et al., 2001b). Thus, JAM
blockade inhibits reovirus binding and growth.
An important criterion for virus receptor identification
is the demonstration that expression of a candidate re-
ceptor in nonpermissive cells is sufficient to confer pro-
ductive viral infection. This criterion was satisfied by
expression of JAM in MEL cells, which do not support
infection by non-sialic-acid-binding reovirus strains (Ru-
bin et al., 1992; Chappell et al., 1997), and chicken em-
bryo fibroblast (CEF) cells, which are refractory to infec-
tion by mammalian reoviruses. MEL cells transfected
with hJAM support the growth of T1L and T3SA (Barton
et al., 2001b), neither of which binds sialic acid (Chappell
et al., 1997; Barton et al., 2001a). Likewise, CEF cells
transfected with either hJAM or murine JAM (mJAM) sup-
port the growth of T1L, T3SA, and T3SA (Barton et al.,
2001b). In contrast, CEF cells transfected with human
coxsackievirus and adenovirus receptor (hCAR) (Bergel-
son et al., 1997) do not support infection by these reovi-
rus strains. These results provide additional evidence
that JAM serves as a receptor for serotype 1 and 3
reovirus strains.
To exclude the possibility that JAM upregulates or
stabilizes expression of an endogenous reovirus recep-
tor, or enhances reovirus replication at a postattachment
step, surface plasmon resonance was used to determine
whether reovirus virions and 1 protein are capable of
direct interaction with hJAM. Virions of T3SA, T3SA,
T1L, and T3D bind to a fusion protein consisting of the
rabbit Ig Fc domain linked to the extracellular domain of
hJAM (Fc-hJAM) (Barton et al., 2001b) but not to a fusion
of the rabbit Fc Ig domain to hCAR (Bergelson et al.,
1997). Purified recombinant T3D 1 also binds specifi-
cally to an Fc-hJAM-coated biosensor surface, and ki-
netic analysis of the 1-Fc-hJAM interaction indicates a
KD of approximately 9  10
8 M (Barton et al., 2001b).
This finding indicates that reovirus binding to JAM is
mediated directly by the 1 protein. Importantly, the car-
boxy-terminal 1 tryptic cleavage fragment, which lacks
the sialic-acid-binding domain, binds to the Fc-hJAM
surface with a KD similar to that of full-length 1 (6 
108 M) (Barton et al., 2001b). Therefore, a fragment of 1
containing the head domain binds directly to the extra-
cellular region of hJAM in a manner that does not require
1–carbohydrate interactions. Together, these results
demonstrate that hJAM and mJAM function as serotype-
independent reovirus receptors.
REOVIRUS BINDING TO BOTH SIALIC ACID AND
JAM IS REQUIRED FOR INDUCTION
OF APOPTOSIS
Reovirus induces the biochemical and morphological
hallmarks of apoptosis in cultured cells (Tyler et al., 1995;
Rodgers et al., 1997; Clarke et al., 2000; Connolly et al.,
2000) and in vivo (Oberhaus et al., 1997; DeBiasi et al.,
2001). Insight into mechanisms by which reovirus elicits
apoptosis has emerged from studies of viral prototype
strains that vary in the capacity to induce this cellular
response. Reovirus strain T3D induces apoptosis to a
substantially greater extent than T1L in L cells (Tyler et
al., 1995), Madin–Darby canine kidney (MDCK) cells
(Rodgers et al., 1997), and HeLa cells (Connolly et al.,
2001). Differences in the capacity of these strains to
induce apoptosis are determined primarily by the viral S1
gene (Tyler et al., 1995; Rodgers et al., 1997; Connolly et
al., 2001); however, the M2 gene makes a secondary
contribution to the magnitude of the apoptotic response
(Tyler et al., 1995; Rodgers et al., 1997).
The reovirus S1 gene encodes two proteins, attach-
ment protein 1 and nonstructural protein 1s (Ernst and
Shatkin, 1985; Jacobs and Samuel, 1985; Sarkar et al.,
1985). Reovirus 1s-null mutant T3C84-MA induces ap-
optosis with an efficiency equivalent to its 1s-express-
ing parental strain T3C84 (Rodgers et al., 1998), indicat-
ing that the 1 protein is the S1 gene product responsi-
ble for mediating differences in apoptosis efficiency. This
discovery, along with the finding that strain-specific dif-
ferences in viral growth and apoptosis induction are not
genetically linked (Rodgers et al., 1997), led to the hy-
pothesis that apoptosis is triggered by a signaling path-
way initiated by early steps in the virus replication cycle.
In support of this hypothesis, we found that reovirus
infection leads to activation of nuclear factor kappa B
(NF-B) (Connolly et al., 2000), a family of transcription
factors known to play important roles in regulating cel-
lular stress responses, including apoptosis (Pahl, 1999).
Reovirus is capable of activating NF-B in a variety of
cultured cell lines including L cells, MDCK cells, and
HeLa cells (Connolly et al., 2000). NF-B complexes
activated by reovirus are composed of NF-B subunits
p50 and p65 (RelA) (Connolly et al., 2000). Depending on
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the cell type, NF-B activation is first detected 2 to 4 h
after viral adsorption and peaks 6 to 10 h after infection
(Connolly et al., 2000). Apoptosis induced by reovirus is
significantly reduced in cells treated with a proteasome
inhibitor and in cells expressing a transdominant inhib-
itor of NF-B. In addition, reovirus-induced apoptosis is
blocked in cells deficient in the expression of the p50 or
p65 NF-B subunits (Connolly et al., 2000). These find-
ings demonstrate that NF-B plays a proapoptotic role
during reovirus infection. In some cell types, reovirus
infection leads to expression of death receptors DR4 and
DR5 and their proapoptotic ligand TRAIL (Clarke et al.,
2000), which may be regulated by NF-B.
Linkage of the S1 gene to the magnitude of reovirus-
induced apoptosis suggested that the capacity of attach-
ment protein 1 to bind different cell-surface receptors
regulates the efficiency of the apoptotic response. Direct
confirmation of this hypothesis was first demonstrated in
studies using isogenic point-mutant strains T3SA and
T3SA. Sialic-acid-binding strain T3SA induces apo-
ptosis to a much greater extent than non-sialic-acid-
binding strain T3SA in both HeLa cells and L cells
(Connolly et al., 2001). Enzymatic removal of cell-surface
sialic acid with neuraminidase, or blockade of virus bind-
ing to sialic acid using SLL, abolishes the capacity of
T3SA to induce apoptosis (Connolly et al., 2001). Fur-
thermore, infection with T3SA, but not T3SA, acti-
vates NF-B. The capacity of T3SA to activate NF-B is
inhibited by neuraminidase treatment, indicating that
sialic-acid binding is also necessary for NF-B activation
following reovirus infection (Connolly et al., 2001). These
results demonstrate that the capacity to bind sialic acid
significantly enhances the capacity of reovirus to activate
NF-B and induce apoptosis. However, JAM also plays a
critical role in these processes. At high m.o.i.’s (100
PFU/cell), T3SA can bind and enter cells via a JAM-
independent pathway mediated by binding sialic acid
(Barton et al., 2001b). Although viral replication is efficient
following sialic-acid-mediated entry, T3SA can neither
activate NF-B nor induce apoptosis in the absence of
JAM binding (Barton et al., 2001b). Together, these find-
ings show that reovirus binding to both sialic acid and
JAM is required to induce maximal levels of apoptosis.
We think it likely that multivalent interactions of 1 with
sialic acid and JAM surpasses a critical cellular activa-
tion threshold required for NF-B activation and apopto-
sis induction (Fig. 3). It is possible that sialic acid en-
gagement by 1 induces conformational changes in JAM
or results in prolonged receptor activation, either of
which could lead to initiation of signals required for
FIG. 3. Models of reovirus–JAM interactions at the cell surface. (A) Non-sialic-acid-binding reovirus strains like T1L and T3SA use JAM as a
receptor. Binding of these strains to JAM leads to virus internalization but does not induce signals that activate NF-B. (B) Sialic-acid-binding reovirus
strains like T3D and T3SA bind both sialic acid and JAM. The membrane-proximal Ig domain of hJAM contains two N-linked glycosylation sites (Liu
et al., 2000), one of which is schematically indicated. The dual ligation of JAM and JAM-bound sialic acid may induce JAM crosslinking or
conformational alterations leading to initiation of signals required for NF-B activation and apoptosis. (C) Sialic-acid-binding reovirus strains also may
activate intracellular signaling pathways by the simultaneous crosslinking of JAM and other sialylated cell-surface proteins. Figure reprinted from Cell
104, Barton et al., “Junction Adhesion Molecule Is a Receptor for Reovirus,” 441–451, 2001, with permission from Elsevier Science.
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reovirus-induced apoptosis. In support of this possibility,
JAM contains two potential N-linked glycosylation sites
in the membrane-proximal Ig-like domain (Liu et al.,
2000). It is also conceivable that the specific sialic acid
residues bound by reovirus are conjugated to other cell-
surface proteins in close proximity to JAM and that the
juxtaposition of these proteins with JAM is required to
generate a proapoptotic signal. In either case, the central
role of sialic acid and JAM in reovirus-induced apoptosis
suggests that receptor-linked signaling responses con-
tribute to the pathogenesis of reovirus infection.
Although receptor binding is an important determinant
of apoptosis induced by reovirus, there is evidence to
suggest that steps in reovirus replication subsequent to
viral attachment potentiate signals that lead to apopto-
sis. In other systems, activation of NF-B as a result of
receptor–ligand interactions typically occurs more rap-
idly than that observed following reovirus infection
(Traenckner et al., 1995). The kinetics of reovirus-induced
NF-B activation raise the possibility that viral replication
steps following viral attachment are required to elicit an
apoptotic response. Additional support for this idea
comes from the finding that the M2 gene influences the
efficiency of apoptosis induction (Tyler et al., 1995; Rodg-
ers et al., 1997). The M2 gene encodes 1/1C, an
outer-capsid protein that plays important roles in viral
disassembly and membrane penetration (Nibert and
Fields, 1992; Lucia-Jandris et al., 1993; Hooper and
Fields, 1996). Therefore, it is possible that steps in reo-
virus entry synergize with receptor engagement to elicit
apoptosis.
REOVIRUS TROPISM REVISITED: HOW DO
1–RECEPTOR INTERACTIONS DETERMINE
NEURAL TROPISM?
Since the discovery that the viral attachment step
determines the route of spread in the host, specificity of
tissue tropism, and disease outcome, limited progress
has been made toward determining how 1 influences
reovirus neuroinvasion and neurovirulence phenotypes.
A fundamental roadblock to these studies has been an
incomplete understanding of the 1 domains involved in
receptor binding and the lack of defined cellular mole-
cules that serve as 1 receptors. The biochemical defi-
nition of sialic-acid-binding and JAM-binding domains in
1, the cloning of JAM as a 1 receptor, and the eluci-
dation of the role of 1 receptors in the biophysics of
reovirus attachment and the induction of apoptosis en-
able the development of testable models of reovirus
tropism.
The differential tropism of type 1 and type 3 reovirus in
the murine CNS led to the hypothesis that type 1 and
type 3 strains bind distinct receptors expressed on
ependymal cells and neurons, respectively. Models of
1-dependent tropism have focused primarily on the role
of proteinaceous receptors for 1, since it was difficult to
reconcile a mechanism by which the ligation of a univer-
sally expressed carbohydrate (e.g., sialic acid) could
confer the exquisite neural tropism observed for type 3
reovirus strains. Furthermore, since mutations in the
head domain of T3D 1 are capable of modulating the
pattern of neural tropism exhibited by this strain (Bassel-
Duby et al., 1986; Kaye et al., 1986), it was thought that
these mutations function by altering the interaction of 1
with the head receptor. However, since JAM binds to and
confers infection by both type 1 and type 3 reovirus
strains, it is unlikely that JAM is the sole determinant of
serotype-dependent differences in reovirus tropism in
the CNS.
These observations lead us to propose three models
of reovirus neural tropism. According to the first model,
cell-surface carbohydrate plays the dominant role in de-
termining the types of CNS cells infected by a given
reovirus strain. Although both type 1 and type 3 reovirus
strains bind JAM, they differ in the types of cell-surface
carbohydrate bound (Dermody et al., 1990; Chappell et
al., 2000). An important component of the neonatal neu-
ronal glycocalyx is polysialic acid (PSA) (Rutishauser and
Landmesser, 1991, 1996). It is possible that PSA mediates
reovirus tropism for neurons as either a dominant inhib-
itor of type 1 reovirus adsorption or an adhesive accel-
erant to infection by type 3 strains. PSA may form a highly
charged barrier that repels type 1 strains in the intersti-
tial spaces. Conversely, sialic-acid-binding type 3 strains
may adhere strongly to the neural surface and utilize PSA
as an entry mediator in the absence of JAM. As a logical
extension of this model, it is possible that ependymal
cells express the carbohydrate bound by type 1 1,
thereby mediating adhesion of type 1 reovirus strains to
the ependymal cell layer.
The second model holds that JAM is responsible for
reovirus tropism in cooperation with carbohydrate as a
coreceptor. Adhesion of type 3 1 to PSA may be a
prerequisite to permit access to JAM in a mechanism
analogous to the sialic-acid-mediated enhancement of
T3SA infection of HeLa cells (Barton et al., 2001a). In
support of this model, neutralization-escape variants of
T3D contain single point mutations in the 1 head do-
main (Bassel-Duby et al., 1986) and are strikingly atten-
uated in virulence (Spriggs and Fields, 1982; Spriggs et
al., 1983). These findings provide circumstantial evi-
dence that the JAM-binding 1 head contributes to reo-
virus infection of neurons. A JAM-dependent model of
reovirus tropism also might explain the age dependence
of reovirus virulence. Weanling mice rapidly become re-
sistant to reovirus neural replication and disease in the
first few weeks of life (Tardieu et al., 1983). During em-
bryonic development of the murine CNS, the neuroepi-
thelial cell layer gradually loses its epithelial character,
and neural precursors lose the capacity to form TJs and
downregulate integral TJ proteins, including occludin
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(Nakai and Fujita, 1994; Aaku-Saraste et al., 1996). JAM
expression in the developing murine CNS has not been
characterized; however, it is possible that low levels of
JAM are expressed at birth and then quickly decline in
the neonatal period as remodeling of the CNS is com-
pleted, thus eliminating the means by which reovirus
accesses the neural surface.
According to the third model, JAM serves as a sero-
type-independent reovirus receptor at some sites within
the host, and unidentified molecules serve as serotype-
dependent reovirus receptors in the CNS. JAM is ex-
pressed on many cell types that are known targets for
reovirus infection in vivo, including intestinal epithelium,
bile duct epithelium, lung epithelium, and leukocytes
(Martin-Padura et al., 1998; Williams et al., 1999; Liu et al.,
2000). These observations are consistent with the exten-
sive and overlapping tissue distribution of type 1 and
type 3 reovirus infection in mice, particularly within the
intestine (Tyler, 2001). However, it is possible that reovi-
rus uses alternate receptors at neural sites. In support of
this possibility, three proteins have been identified that
display significant homology to JAM: A33 antigen (Heath
et al., 1997), VE-JAM (Palmeri et al., 2000), and JAM2
(Cunningham et al., 2000). These or novel reovirus re-
ceptors may demonstrate serotype-specific interactions
with 1 in the CNS. Studies are now in progress using
reovirus strains that vary in receptor utilization and mice
genetically altered in JAM expression to explore these
possibilities. This work will clarify mechanisms of reovi-
rus neurovirulence and facilitate a more precise under-
standing of the role of viral receptor binding in reovirus-
induced disease.
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